Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Perco

Showing results (51-60 of 111) with videos related to

Pageof 12
Sort By:
Computational and Structural Biotechnology Journal|July 19, 2019
Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular ProfilesChristian Koppelstaetter, Johannes Leierer, Michael Rudnicki, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2011
Data and knowledge management in cross-Omics research projectsMartin Wiesinger, Martin Haiduk, Marco Behr, et al.
Proteomics|January 31, 2025
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and ApproachesPaul Perco, Matthias Ley, Kinga Kęska-Izworska, et al.
JCI Insight|June 21, 2019
Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney diseasePaul Perco, Wenjun Ju, Julia Kerschbaum, et al.
Scientific Reports|May 5, 2018
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft functionPaul Perco, Andreas Heinzel, Johannes Leierer, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 3, 2015
Disease map-based biomarker selection and pre-validation for bladder cancer diagnosticMarine De Paoli, Paul Perco, Irmgard Mühlberger, et al.
BMC Medical Genomics|December 26, 2014
A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseasesHannes Neuwirt, Paul Perco, Alexander Kainz, et al.
Proteomics|December 31, 2024
Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney DiseaseIoanna K Mina, Luis F Iglesias-Martinez, Matthias Ley, et al.
Pageof 12

Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Computational and Structural Biotechnology Journal|July 19, 2019
Computational Drug Screening Identifies Compounds Targeting Renal Age-associated Molecular ProfilesChristian Koppelstaetter, Johannes Leierer, Michael Rudnicki, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 4, 2011
Data and knowledge management in cross-Omics research projectsMartin Wiesinger, Martin Haiduk, Marco Behr, et al.
Proteomics|January 31, 2025
Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and ApproachesPaul Perco, Matthias Ley, Kinga Kęska-Izworska, et al.
JCI Insight|June 21, 2019
Identification of dicarbonyl and L-xylulose reductase as a therapeutic target in human chronic kidney diseasePaul Perco, Wenjun Ju, Julia Kerschbaum, et al.
Scientific Reports|May 5, 2018
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft functionPaul Perco, Andreas Heinzel, Johannes Leierer, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|September 3, 2015
Disease map-based biomarker selection and pre-validation for bladder cancer diagnosticMarine De Paoli, Paul Perco, Irmgard Mühlberger, et al.
BMC Medical Genomics|December 26, 2014
A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseasesHannes Neuwirt, Paul Perco, Alexander Kainz, et al.
Proteomics|December 31, 2024
Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney DiseaseIoanna K Mina, Luis F Iglesias-Martinez, Matthias Ley, et al.
Pageof 12